Reduction of revascularization with icosapent ethyl in patients with hypertriglyceridemia - PACE-CME

Reduction of revascularization with icosapent ethyl in patients with hypertriglyceridemia

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

FCS: Enhancing the Diagnosis
FCS: Enhancing the Diagnosis
MinuteCE®
FCS: Enhancing the Diagnosis
1.00 program credit
- Daniel Gaudet, MD, PhD
1.00 program credit
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
MinuteCE®
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
1.00 program credit
- Børge G. Nordestgaard, MD, DMSc
- Kausik Ray, MBChB, MD, MPhil
1.00 program credit
APOC3 Inhibition: A Novel Approach to Lowering TGs
APOC3 Inhibition: A Novel Approach to Lowering TGs
MinuteCE®
APOC3 Inhibition: A Novel Approach to Lowering TGs
1.00 program credit
- Børge G. Nordestgaard, MD, DMSc
- Kausik Ray, MBChB, MD, MPhil
1.00 program credit
Latest Clinical Trial Outcomes and Breakthroughs for FCS
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®
Latest Clinical Trial Outcomes and Breakthroughs for FCS
1.00 program credit
- Daniel Gaudet, MD, PhD
- Pam R. Taub, MD, FACC, FASPC
1.00 program credit